Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes of platinum-based chemotherapy plus cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck: comparison between platinum-sensitive and platinum-resistant patients.
Sato H, Tsukahara K, Okamoto I, Katsube Y, Shimizu A, Kondo T, Hanyu K, Fushimi C, Okada T, Miura K. Sato H, et al. Among authors: okada t. Acta Otolaryngol. 2019 Feb;139(2):201-205. doi: 10.1080/00016489.2018.1551623. Epub 2019 Feb 22. Acta Otolaryngol. 2019. PMID: 30794080
Hematological predictive markers for recurrent or metastatic squamous cell carcinomas of the head and neck treated with nivolumab: A multicenter study of 88 patients.
Matsuki T, Okamoto I, Fushimi C, Sawabe M, Kawakita D, Sato H, Tsukahara K, Kondo T, Okada T, Tada Y, Miura K, Omura G, Yamashita T. Matsuki T, et al. Among authors: okada t. Cancer Med. 2020 Jul;9(14):5015-5024. doi: 10.1002/cam4.3124. Epub 2020 May 22. Cancer Med. 2020. PMID: 32441463 Free PMC article.
Age-based efficacy and safety of nivolumab for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter retrospective study.
Kondo T, Okamoto I, Sato H, Koyama N, Fushimi C, Okada T, Masubuchi T, Miura K, Matsuki T, Yamashita T, Omura G, Takahashi H, Tsukahara K. Kondo T, et al. Among authors: okada t. Asia Pac J Clin Oncol. 2020 Dec;16(6):340-347. doi: 10.1111/ajco.13374. Epub 2020 Jun 23. Asia Pac J Clin Oncol. 2020. PMID: 32573033
Predicting the efficacy of chemoradiotherapy for locally advanced human papilloma virus-related oropharyngeal squamous cell carcinoma using one course of TPF chemotherapy.
Kondo T, Tsukahara K, Okamoto I, Sato H, Okada T, Maruyama R, Hihara K, Ito T, Takeda A, Kikawada N, Aihara Y, Ogawa Y. Kondo T, et al. Among authors: okada t. Eur Arch Otorhinolaryngol. 2021 Sep;278(9):3497-3506. doi: 10.1007/s00405-020-06549-9. Epub 2021 Jan 2. Eur Arch Otorhinolaryngol. 2021. PMID: 33386967
4,973 results